• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

德克萨斯州埃尔帕索的跨国耐多药结核病病例的结局。

Outcomes of multidrug-resistant tuberculosis among binational cases in El Paso, Texas.

机构信息

Division of Pulmonary and Critical Care Medicine, Department of Medicine, Cleveland Clinic Foundation, Weston, Florida 33331, USA.

出版信息

Am J Trop Med Hyg. 2010 Nov;83(5):1056-8. doi: 10.4269/ajtmh.2010.10-0145.

DOI:10.4269/ajtmh.2010.10-0145
PMID:21036837
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2963969/
Abstract

In the United States, multidrug-resistant tuberculosis (MDR-TB) is more commonly seen among foreign-born patients. We report outcomes for 46 patients with MDR-TB who were born in Mexico and treated along the United States-Mexico border. According to our definition, 30 were cured, 3 showed treatment failure, 3 died, and 10 abandoned treatment. Multidrug-resistant tuberculosis can be successfully treated on an ambulatory basis.

摘要

在美国,耐多药结核病(MDR-TB)在外国出生的患者中更为常见。我们报告了 46 名出生于墨西哥并在美国-墨西哥边境接受治疗的耐多药结核病患者的结局。根据我们的定义,30 人治愈,3 人治疗失败,3 人死亡,10 人放弃治疗。耐多药结核病可以在门诊基础上成功治疗。

相似文献

1
Outcomes of multidrug-resistant tuberculosis among binational cases in El Paso, Texas.德克萨斯州埃尔帕索的跨国耐多药结核病病例的结局。
Am J Trop Med Hyg. 2010 Nov;83(5):1056-8. doi: 10.4269/ajtmh.2010.10-0145.
2
Prevalence and risk factors of drug-resistant tuberculosis along the Mexico-Texas border.墨西哥-得克萨斯边境地区耐多药结核病的患病率及危险因素
Am J Public Health. 2000 Feb;90(2):271-3. doi: 10.2105/ajph.90.2.271.
3
Tuberculosis along the United States-Mexico border, 1993-2001.1993 - 2001年美国与墨西哥边境地区的结核病情况
Rev Panam Salud Publica. 2004 Jul;16(1):23-34. doi: 10.1590/s1020-49892004000700004.
4
Epidemiology of Primary Multidrug-Resistant Tuberculosis, Vladimir Region, Russia.俄罗斯弗拉基米尔地区原发性耐多药结核病的流行病学
Emerg Infect Dis. 2015 Nov;21(11):2048-51. doi: 10.3201/eid2111.150813.
5
Representative drug susceptibility patterns for guiding design of re-treatment regimens for multidrug-resistant tuberculosis in Iran.指导伊朗耐多药结核病再治疗方案设计的代表性药敏模式。
Respirology. 2008 Jan;13(1):108-11. doi: 10.1111/j.1440-1843.2007.01201.x.
6
Multidrug-resistant tuberculosis in Alberta and British Columbia, 1989 to 1998.1989年至1998年艾伯塔省和不列颠哥伦比亚省的耐多药结核病
Can Respir J. 1999 Mar-Apr;6(2):155-60. doi: 10.1155/1999/456395.
7
Impact of country of origin on drug-resistant tuberculosis among foreign-born persons in British Columbia.原籍国对不列颠哥伦比亚省外国出生者耐多药结核病的影响。
Int J Tuberc Lung Dis. 2006 Aug;10(8):844-50.
8
Extensively drug-resistant tuberculosis in california, 1993-2006.1993 - 2006年加利福尼亚州的广泛耐药结核病
Clin Infect Dis. 2008 Aug 15;47(4):450-7. doi: 10.1086/590009.
9
Limited Scope of Shorter Drug Regimen for MDR TB Caused by High Resistance to Fluoroquinolone.氟喹诺酮类药物高度耐药导致耐多药结核病较短疗程的局限性。
Emerg Infect Dis. 2019 Sep;25(9):1760-1762. doi: 10.3201/eid2509.190105.
10
A study of clinical profile of cases of MDR-TB and evaluation of challenges faced in initiation of second line Anti tuberculosis treatment for MDR-TB cases admitted in drug resistance tuberculosis center.耐多药结核病病例临床特征研究及耐药结核病中心收治的耐多药结核病病例开始二线抗结核治疗所面临挑战的评估。
Indian J Tuberc. 2019 Jul;66(3):358-363. doi: 10.1016/j.ijtb.2016.11.031. Epub 2017 Feb 10.

引用本文的文献

1
Patient support for tuberculosis patients in low-incidence countries: A systematic review.低发病国家中结核病患者的患者支持:系统评价。
PLoS One. 2018 Oct 10;13(10):e0205433. doi: 10.1371/journal.pone.0205433. eCollection 2018.
2
Multidrug-resistant tuberculosis treatment adherence in migrants: a systematic review and meta-analysis.移民人群中耐多药结核病治疗依从性:系统评价和荟萃分析。
BMC Med. 2018 Feb 22;16(1):27. doi: 10.1186/s12916-017-1001-7.
3
Detection of latent tuberculosis infection among migrant farmworkers along the US-Mexico border.美国-墨西哥边境流动农场工人中潜伏性结核感染的检测
BMC Infect Dis. 2016 Nov 3;16(1):630. doi: 10.1186/s12879-016-1959-3.
4
Association between Directly Observed Therapy and Treatment Outcomes in Multidrug-Resistant Tuberculosis: A Systematic Review and Meta-Analysis.直接观察治疗与耐多药结核病治疗结果之间的关联:一项系统评价和荟萃分析
PLoS One. 2016 Mar 1;11(3):e0150511. doi: 10.1371/journal.pone.0150511. eCollection 2016.
5
Interferon Gamma-Based Detection of Latent Tuberculosis Infection in the Border States of Nuevo Leon and Tamaulipas, Mexico.基于干扰素γ检测墨西哥新莱昂州和塔毛利帕斯州边境地区的潜伏性结核感染
Front Public Health. 2015 Sep 30;3:220. doi: 10.3389/fpubh.2015.00220. eCollection 2015.
6
Border Lookout: Enhancing Tuberculosis Control on the United States-Mexico Border.边境瞭望:加强美墨边境的结核病防控
Am J Trop Med Hyg. 2015 Oct;93(4):747-51. doi: 10.4269/ajtmh.15-0300. Epub 2015 Aug 24.
7
A population-based study of first and second-line drug-resistant tuberculosis in a high-burden area of the Mexico/United States border.墨西哥/美国边境高负担地区一线和二线耐药结核病的基于人群的研究。
Mem Inst Oswaldo Cruz. 2013 Apr;108(2):160-6. doi: 10.1590/0074-0276108022013006.

本文引用的文献

1
Multidrug-resistant and extensively drug-resistant tuberculosis in the West. Europe and United States: epidemiology, surveillance, and control.耐多药和广泛耐药结核病在西方。欧洲和美国:流行病学、监测和控制。
Clin Chest Med. 2009 Dec;30(4):637-65, vii. doi: 10.1016/j.ccm.2009.08.015.
2
Drug resistant Mycobacterium tuberculosis in Mexico.墨西哥的耐药结核分枝杆菌
J Infect Dev Ctries. 2009 Apr 30;3(3):162-8. doi: 10.3855/jidc.31.
3
Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis.耐多药结核病患者的治疗结果:系统评价与荟萃分析。
Lancet Infect Dis. 2009 Mar;9(3):153-61. doi: 10.1016/S1473-3099(09)70041-6.
4
Tuberculosis among foreign-born persons in the United States.美国出生的外国人群中的结核病。
JAMA. 2008 Jul 23;300(4):405-12. doi: 10.1001/jama.300.4.405.
5
Public-private collaboration for multidrug-resistant tuberculosis control in New York City.纽约市控制耐多药结核病的公私合作
Int J Tuberc Lung Dis. 2006 Jun;10(6):639-48.
6
Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis.使用统一标准:耐多药结核病的治疗结果定义
Int J Tuberc Lung Dis. 2005 Jun;9(6):640-5.
7
Treatment of multidrug-resistant tuberculosis in San Francisco: an outpatient-based approach.旧金山耐多药结核病的治疗:一种基于门诊的方法。
Clin Infect Dis. 2005 Apr 1;40(7):968-75. doi: 10.1086/428582. Epub 2005 Mar 2.
8
Treatment and outcome analysis of 205 patients with multidrug-resistant tuberculosis.205例耐多药结核病患者的治疗与转归分析
Am J Respir Crit Care Med. 2004 May 15;169(10):1103-9. doi: 10.1164/rccm.200308-1159OC. Epub 2004 Jan 23.
9
American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis.美国胸科学会/疾病控制与预防中心/美国传染病学会:结核病的治疗
Am J Respir Crit Care Med. 2003 Feb 15;167(4):603-62. doi: 10.1164/rccm.167.4.603.
10
Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru.秘鲁利马针对耐多药结核病的社区治疗。
N Engl J Med. 2003 Jan 9;348(2):119-28. doi: 10.1056/NEJMoa022928.